Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 736327, 8 pages
http://dx.doi.org/10.1155/2009/736327
Research Article

A New Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Bisoprolol in Human Plasma Samples

1Center for Drug Evaluation, Antibiotice S.A., Valea Lupului, 1 Street, 707410 Iasi, Romania
2Department of Analytical Chemistry, Faculty of Pharmacy, “Gr.T. Popa” University of Medicine and Pharmacy, 700115 Iasi, Romania
3Faculty of Chemical Engineering and Environment Protection, Technical University “Gheorghe Asachi”, 71st A Mangeron Dimitrie Street, 7000050 Iasi, Romania

Received 6 March 2009; Revised 2 June 2009; Accepted 10 June 2009

Academic Editor: Kennerly S. Patrick

Copyright © 2009 Gabriela Peste et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Liquid chromatography (LC) coupled with mass spectrometry (MS) detection is one of the most powerful analytical tools for organic compound analysis. The advantages of using LC/MS methods over HPLC methods include: selectivity, chromatographic integrity, peak assignment, structural information, and rapid method development. In this paper, a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for the determination of bisoprolol in human plasma samples, using metoprolol as internal standard and liquid-liquid extraction procedure. The assay has proven to be sensitive, specific and reproducible, suitable to determine the bisoprolol concentration, following a single oral administration of a 10 mg bisoprolol tablet in 22 healthy volunteers, in the bioequivalence study of Bisoprolol 10 mg coated tablets, produced by Antibiotice S.A. versus Concor 10 mg, produced by Merck.

1. Introduction

Bisoprolol fumarate is a synthetic cardioselective -adrenergic blocker. Chemically, bisoprolol fumarate is (±)-1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate ( ) [1]. It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. The S( ) enantiomer is responsible for most of the beta-blocking activity.

The objectives of this work were to develop and to validate a simple, accurate, rapid and economic LC-tandem mass spectrometry method for the determination of bisoprolol in human plasma samples, using liquid-liquid extraction, and to present some of this method applications.

2. Materials and Methods

2.1. Instruments

All analyses were performed using the Agilent 1100 LC/MSD Trap XCT system. The system compenents included the Agilent 1100 Degasser, Agilent 1100 Binary Pump, Agilent 1100 Autosampler, Agilent 1100 Mass Selective Detector. The Bruker Daltonik software was used for system control and data acquisition. An analytical balance Mettler-Toledo XP56, a Sigma 2–16 K centrifuge and a Vibramax 110 shaker were used for the sample preparation.

The separation was performed using a reverse phase column (Zorbax SB-C18 Solvent Saver Plus,  mm, 3.5  m, supplied by Agilent, USA).

2.2. Reagents

All solvents and other chemicals (acetonitrile, methanol, sodium hydroxide, tert-butyl methyl ether, water, formic acid) were HPLC grade provided by Merck’s Chemical Co., Darmstadt, Germany. The reference substances of bisoprolol and metoprolol (internal standard) were supplied from the USP Pharmacopoeia. The human plasma was obtained from Center for Blood Drawing and Preservation, Iasi, Romania.

2.3. Bisoprolol Stock Solution

Bisoprolol was dissolved in methanol, obtaining a bisoprolol stock solution of 500  g/mL.

2.4. Metoprolol Stock Solution

The internal standard, metoprolol, was dissolved in methanol, obtaining a metoprolol stock solution of 500  g/mL.

2.5. Solutions for Linearity Response

Eight bisoprolol concentrations were prepared in human plasma, covering the expected range of observed concentrations (1–100 ng/mL). The theoretical concentrations of bisoprolol calibration standards were 1.0, 2.0, 10.0, 20.0, 40.0, 60.0, 80.0, and 100.0 ng/mL.

2.6. Quality Control Samples

Plasma samples having bisoprolol theoreticals concentrations of 3 ng/mL, 25 ng/mL and 75 ng/mL were considered to be appropriate to be used to validate the bioanalytical method.

2.7. Samples for Recovery

In order to determine the analyte and the internal standard recovery from the plasma, water samples containing the same bisoprolol concentrations as the quality control samples were prepared.

2.8. Samples Preparation

After alkalization with sodium hydroxide and addition internal standard solution, the 0.250 mL plasma sample was extracted with 2 mL tert-butyl methyl ether. The solvent was evaporated using a flow air at 40°C. The solid residue was dissolved in a 0.250 mL mixture 0.1% formic acid solution—acetonitrile (50-50, v/v).

3. Results and Discussions

3.1. The Development of the LC-Tandem Mass Spectrometry Method

LC separation of bisoprolol and internal standard, metoprolol, has been carried out using the mobiles phases consisting of differents aqueous solutions and methanol or acetonitrile as organic phase. Hernardo et al. [2] used a acetonitrile as organic mobile phase to lead to shorter retention times and better resolution of the bisoprolol and internal standard. Formic acid solution as additive in water was used by Li et al. [3] to improve the sensitivity of MS detection.

The LC-MS/MS method for determination of bisoprolol in human plasma samples described in this paper was performed using a mobile phase consist in mixture 0.1% formic acid solution (pH 3)—acetonitrile (50-50, v/v). The LC system was operated at 0.3 mL/min, using the binary pump. The column temperature was 40°C. The injection volume was 5  and represented no more 5% of the total sample available for injection. Short run times of about 3 minutes were achieved for both bisoprolol and internal standard, metoprolol. Bisoprolol was eluted at 1.7 minutes and metoprolol at 1.9 minutes. The peaks of interest were free from interfering peaks at their respective retention time.

To minimize undesirable fragmentation voltages were tested from 80 to 200 V. At 100 V, the MS response of bisoprolol and metoprolol showed both minimal undesirable fragmentation and highest response.

The mass transition ion-pair was followed as m/z .1 for bisoprolol and m/z , for metoprolol, as sustained Bhatt et al. [4].

The protonated molecular ion of bisoprolol [M+H]+  (m/z 326.3) was tested to give the highest sensitivity. Based on the optimization results, m/z 116.2 was selected as the quantifier ion. Also, the protonated molecular ion of metoprolol [M+H]+  (m/z 268) was tested and m/z 116.2 was selected as the quantifier ion. We have chosen products ions with the same m/z value for bisoprolol and metoprolol, respectively, because a possible suppression effect would influence the quantification of both the analyte and internal standard in the same way.

Other mass spectrometric parameters (gas temperature, gas pressure and gas flow) were adjusted to get a maximum signal for bisoprolol. The nebulizing gas flow rate was set at 10 l/min, drying gaz temperature at 350°C, and the capillary voltage at 4000 V. The response of bisoprolol and metoprolol were measured by MRM in the positive ionization mode with a collision energy of 20 V.

3.2. Validation of the LC-Tandem Mass Spectrometry Method

The method was validated according Guidance for Industry: Bioanalytical Method Validation [5].

The parameters usually examined in the validation process are selectivity/specificity, linearity, limit of quantification, accuracy and precision, stability.

3.2.1. Selectivity

The reversed-phase HPLC method described in this paper has been tested for possible interferences from other plasma factors. Plasma aliquots from six different sources were assessed for analysis in order to investigate the plasma components behavior.

As it can be seen in Figure 1, no overlapping peaks were detected at bisoprolol and internal standard retention time, 1.7 minutes and 1.9 minutes, respectively. The bioanalytical method proved to be selective.

fig1
Figure 1: Chromatogram recorded for blank plasma sample.
3.2.2. Linearity and Lower Limit of Quantification

The linearity was investigated for a bisoprolol theoreticals concentrations range between 1 ng/mL and 100 ng/mL and the calibration curve was derived by plotting the peak-height ratios of the analyte and the internal standard against the concentration of bisoprolol, using linear regression analysis.

The least-square linear regression revealed that the relationship was linear in the investigated domain, with a correlation coefficient of 0.998599, meeting the acceptance criteria ( ), as it can be seen in Figure 2.

736327.fig.002
Figure 2: The bisoprolol calibration curve obtained for plasma samples described in Section 2.5.

The lower limit of quantification, that is, the lowest standard level with a coefficient of variation less than 20%, is for bisoprolol 0.990 ng/mL with 41.433 signal to noise ratio. The bioanalytical method proved to be sensitive, allowing a precise quantification of concentrations as low as 1 ng/mL (see Figure 3). Results are presented in Table 1.

tab1
Table 1: Lower limit of quantification.
fig3
Figure 3: Chromatogram recorded for plasma containing bisoprolol (0.990 ng/mL, lower limit of quantification) and internal standard.
3.2.3. Accuracy and Precision

Accuracy of the analitycal method represents the degree of closeness of the determined values of an analyte to the nominal/or known true value declared from an individual sample. The accuracy of a bioanalytical method is expressed as a percentage of the nominal value (% nominal).

Precision of the analitycal method represents the degree of dispersal of the values determined of an analyte, from a series of samples processed and analyzed individually from a homogeneous volume of biological matrix. Precision of a bioanalytical method is expressed as the coefficient of variation of the concerned series of determinations, CV (%).

The accuracy and precision of this method were calculated for three concentrations of bisoprolol in human plasma. Six replicate samples having bisoprolol theoreticals concentrations of 3 ng/mL (QC1), 25 ng/mL (QC2) and 75 ng/mL (QC3) were injected into the system. Table 2 summarizes the results obtained for the intraday parameters. The interday precision and accuracy was evaluated also using six aliquots for each quality control sample concentration, prepared and analysed in six different days. The results are presented in Table 3.

tab2
Table 2: Evaluation of intraday precision and accuracy for bisoprolol spiked quality control samples.
tab3
Table 3: Evaluation of interday precision and accuracy for bisoprolol spiked quality control samples.

Intra-and interday precision of analysis was 8% and accuracy range was from 94.170% to 102.540%.

The values for the investigated parameters proved to be lower than the one reported by Oniscu et al. [6], employing a HPLC method with fluorescence detection. Also, Liu et al. [7] reported an accuracy ranged from 89.4%–113%, employing a precipitation with acetonitrile procedure for plasma sample preparations.

3.2.4. Recovery

Recovery of Bisoprolol was evaluated by comparing analyte response of six extracted samples of low, medium, and high quality control samples to those of six appropriately diluted standard solutions. Mean recovery values for Bisoprolol are 76.529, 78.479, and 79.863% at low, medium and high quality control levels, respectively.

For internal standard, mean internal standard response of eighteen extracted samples was compared to the mean internal standard responses of eighteen appropriately diluted internal standard solutions. Mean recovery value for the internal standard is 90.568%.

3.2.5. Stability Tests

To test stability, a series of standards samples was prepared from freshly made stock solutions in the same solvent used for the assay. The lowest and highest concentration of the quality control (3 ng/mL and 75 ng/mL), including the analyte and internal standard (when appropiate) were used. Human plasma samples of each concentration were prepared in enough volume to have multiple aliquots.The aliquots of each concentration were processed and quantified immediately in order to provide the reference (fresh) values and other six aliquots of each concentration were processed for the desired tests.

The following subsections present the procedure carried out and the corresponding results.

(a) Stability of the Analyte after Sample Processing at Room Temperature
Samples prepared at low (QC1) and high (QC3) quality control levels were submitted to the extraction procedure and kept at room temperature under ambient laboratory conditions (stability samples). A calibration curve and 6 replicates of low and high quality control samples (comparison samples) were freshly processed and analyzed with 6 replicates of stability samples in a single run. Concentrations were calculated to determine% change over time.
Bisoprolol is found to be stable for 31 hours at room temperature under ambient laboratory conditions after sample processing with % changes (ratio between mean concentration of stability samples and mean concentration of comparison samples) of and %. Results are presented in Table 4.

tab4
Table 4: Stability of analyte following sample processing at room temperature.

(b) Stability of Analyte in Biological Matrix at Room Temperature
Samples were prepared at low (QC1) and high (QC3) quality control levels. Six replicates of low and high quality control samples were left at room temperature for approximately 4 hours (stability samples). A calibration curve and 6 replicates of low and high quality control samples (comparison samples) were freshly processed with 6 replicates of stability samples and analyzed in a single run. Concentrations were calculated to determine % change over time.
Bisoprolol is found to be stable in human plasma for 4 hours at room temperature with % changes of 3.522 and 3.566%. Results are presented in Table 5.

tab5
Table 5: Stability of analyte in biological matrix at room temperature.

(c) Stability of Analyte in Biological Matrix after 3 Freeze–Thaw Cycles
Samples were prepared at low (QC1) and high (QC3) quality control levels, aliquoted and frozen at °C. Some of the aliquots of quality control samples were subjected to three freeze-thaw cycles (stability samples). The remaining aliquots were not thawed (comparison samples). A calibration curve and 6 replicates of low and high quality control samples (comparison samples) were freshly processed with 6 replicates of stability samples and analyzed in a single run. Concentrations were calculated to determine% change over freeze-thaw cycles. Bisoprolol is found to be stable in human plasma after three freeze-thaw cycles with % changes of 1.920 and 6.212%. Results are presented in Table 6.

tab6
Table 6: Stability of analyte in biological matrix after 3 freeze-thaw cycles at °C.
3.3. The Applications of LC-Tandem Mass Spectrometry Method

The assay has proven to be suitable to determine the bisoprolol concentration in the bioequivalence study of Bisoprolol 10 mg coated tablets produced by Antibiotice S.A. (referred to as test drug) versus Concor 10 mg coated tablets produced by Merck (referred to as reference drug). In Figure 4, average bisoprolol concentrations recorded for 22 volunteers are plotted against time for both test and reference drugs.

736327.fig.004
Figure 4: Average bisoprolol concentrations recorded for the test and reference drugs in the bioequivalence study performed on 22 healthy volunteers.

The concentration profiles are similarly, fitting the results obtained for the in vitro dissolution test (see Figure 5).

736327.fig.005
Figure 5: Average dissolved bisoprolol recorded for test and reference drugs recorded for the in vitro dissolution test.

Based on the determined bisoprolol concentrations, the calculated pharmacokinetic parameters demonstrated that the drug produced by Antibiotice S.A. is bioequivalent with the one produced by Merck.

4. Conclusions

LC-tandem mass spectrometry method described and validated above is sensitive, accurate, precise, rapid, and efficient. The developed method can be applied for the determination of bisoprolol from human plasma samples (e.g., for pharmacokinetic parameters).

References

  1. “Bisoprolol,” in Clarkes's Analysis of Drugs and Poisons, vol. 1, Pharmaceutical Press, London, UK, 2005.
  2. M. D. Hernando, M. Petrovic, A. R. Fernández-Alba, and D. Barceló, “Analysis by liquid chromatography-electrospray ionization tandem mass spectrometry and acute toxicity evaluation for β-blockers and lipid-regulating agents in wastewater samples,” Journal of Chromatography A, vol. 1046, no. 1-2, pp. 133–140, 2004. View at Publisher · View at Google Scholar
  3. S. Li, G. Liu, J. Jia et al., “Simultaneous determination of ten antiarrhythmics drugs and a metabolite in human plasma by liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B, vol. 847, no. 2, pp. 174–181, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. J. Bhatt, G. Subbaiah, S. Kambli et al., “A high throughput and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of bisoprolol in human plasma using multiplexing technique,” Journal of Chromatography B, vol. 852, no. 1-2, pp. 374–381, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. F.D.A., Center for Drug Evaluation and Research (CDER), “Guidance for Industry: Bioanalytical Method Validation,” May 2001. View at Google Scholar
  6. C. Oniscu, C. V. Vlase, and G. Peste, “A new high performance liquid chromatographic method for determination of bisoprolol in plasma samples,” Roumanian Biotechnological Letters, vol. 12, no. 1, pp. 3079–3084, 2007. View at Google Scholar
  7. M. Liu, D. Zhang, Y. Sun, Y. Wang, Z. Liu, and J. Gu, “Liquid chromatographic-electrospray tandem mass spectrometric determination of bisoprolol in human plasma,” Biomedical Chromatography, vol. 21, no. 5, pp. 508–513, 2007. View at Publisher · View at Google Scholar · View at PubMed